Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy.

Liu, Lili; Chen, Juanjuan; Zhang, Yue; Wu, Jun; Hu, Jun; Lin, Zhijian

Liu, Lili; Chen, Juanjuan; Zhang, Yue; Wu, Jun; Hu, Jun; Lin, Zhijian.

Afiliação

Liu L; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China.
Chen J; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China.
Zhang Y; Department of Nephrology, Peking University Shenzhen Hospital, Shenzhen, China.
Wu J; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China.
Hu J; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China.
Lin Z; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China.

Front Immunol ; 13: 986018, 2022.

Article em En | MEDLINE | ID: mdl-36211443

Assuntos

Fatores de Crescimento Neural; Nós Neurofibrosos; Autoanticorpos; Moléculas de Adesão Celular/metabolismo; Humanos; Masculino; Pessoa de Meia-Idade; Rituximab/metabolismo

Palavras-chave

CIDP; IA therapy; anti-Caspr1 antibody; nerve biopsy; nodo-paranodopathies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nós Neurofibrosos / Fatores de Crescimento Neural Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google